Home/Pipeline/VD-002

VD-002

Solid Tumors (NSCLC, Melanoma)

PreclinicalActive

Key Facts

Indication

Solid Tumors (NSCLC, Melanoma)

Phase

Preclinical

Status

Active

Company

About Vidac Pharma

Israeli biotech advancing metabolic reprogramming therapies for cancer and dermatology.

View full company profile

Therapeutic Areas

Oncology Dermatology